Exclusive

Bergman, Ruiz to Introduce Bipartisan Bill Exempting Additional Covered Entities From 340B Rebates

US capitol dome exterior with US flag
U.S. Reps. Jack Bergman (R-Mich.) and Raul Ruiz (D-Calif.) are expected to soon introduce legislation to exempt certain covered entities from a 340B rebate model.
An expected bipartisan-backed U.S. House bill would exempt a range of covered entities, but not major hospitals, from 340B rebates—building [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Stemline Therapeutics 41st Drugmaker to Enact 340B Contract Pharmacy Restrictions

Stemline logo.
Stemline Therapeutics announced its contract pharmacy restrictions for Orserdu will take effect May 18.
A New York-based drugmaker recently announced new contract pharmacy restrictions for covered entities looking to purchase a breast cancer treatment [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Industry Insights Logo

Readiness Over Reaction

SPONSORED CONTENT

Uncertainty has become a constant in the 340B landscape. Legal challenges, shifting manufacturer policies, and evolving oversight have made one thing clear: waiting for definitive answers before taking action is no longer a viable strategy.


For covered

Read More »

Justice Department Tells Federal Judge Washington State’s 340B Contract Pharmacy Access Law is Unconstitutional

U.S. Justice Department builidng
The U.S. Department of Justice urged a federal judge to rule against Washington state's 340B contract pharmacy access law.
The U.S. Department of Justice (DOJ) recently urged a federal judge to strike down Washington state’s new 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

New Tennessee Law Strengthens Grant Requirements for Certain 340B Clinics Receiving In-Kind Funding

The Tennessee state legislature
Tennessee recently enacted a new law tightening oversight of certain 340B clinics that receive in-kind funding.
Tennessee Gov. Bill Lee (R) recently signed provider-backed legislation aimed at strengthening oversight of certain 340B clinics that receive in-kind [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Virginia Drug Affordability Panel Bill Heads Back to Spanberger After Legislature Rejects Amendments

Gov. Abigail Spanberger outdoors
Virginia Gov. Abigail Spanberger (D) will soon decide the fate of a bill that would establish provisions similar to a prescription drug affordability board.
The fate of a Virginia prescription drug affordability advisory panel is in jeopardy after the state legislature rejected Gov. Abigail [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Three Drugmakers to Refund 340B Covered Entities for Overcharges, One Announces NDC Changes

A screenshot of HRSA website
Three drugmakers recently announced refunds to 340B covered entities for overcharges, while one announced NDC changes.
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2024 and 2026, while a New [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
340B Solutions Spotlight

Q: What is the primary problem 340B Referral Compass solves?

Referral Compass helps covered entities (CEs) address one of the most difficult and often underdeveloped areas…

Read More »

News Alert

Federal Judge Strikes Down North Dakota’s 340B Contract Pharmacy Access Law

U.S. District Court for the District of North Dakota.
The U.S. District Court for the District of North Dakota recently struck down the state's 340B contract pharmacy access law.
A North Dakota federal judge on Monday struck down the state’s 340B contract pharmacy access law in a sharply worded [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

News Alert

UPDATED: GOP Lawmakers Accuse Urban Hospitals of Misusing 340B Program at U.S. House Hearing

U.S. Rep. Jason Smith (R-Mo.) at a Ways & Means Committee hearing
U.S. Rep. Jason Smith (R-Mo.) began the House Ways & Means Committee’s hearing by arguing that large hospital systems “manipulate the 340B drug pricing program to keep steep drug discounts for themselves instead of passing the savings to low-income patients.”
Republican members of a key U.S. House panel on Tuesday criticized some 340B urban hospitals’ use of a rural designation—accusing [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live